BofA says Q3 volatility in European telecoms could create opportunities

Hepion unit receives FDA feedback on gambling disorder drug

Investing.com · News 15m ago

SpyGlass Pharma reports 4-year glaucoma implant trial results

Investing.com · News 15m ago

Radnostix submits NRC letter for license transfer to NANO Nuclear

Investing.com · News 15m ago

Gilead to present HIV and antiviral research at IDWeek 2026

Investing.com · News 15m ago

Baird Medical gains regulatory approvals in Vietnam and Egypt

Investing.com · News 15m ago

Knightscope launches digital twin security software at headquarters

Investing.com · News 15m ago

H.B. Fuller rejects Ancora’s bid, to review asset sales

Investing.com · News 15m ago

QTREX regains Nasdaq minimum bid price compliance

Investing.com · News 15m ago

Market Rightfully Lowering ECB Hike Expectations, Says Morgan Stanley’s Sheets

Bloomberg · Markets Video 17m ago

CoreWeave jumps as Goldman Sachs upgrades stock after 25% rout

Investing.com · Investing_news 20m ago